Document Detail


Thromboembolic risk and anticoagulation strategies in patients undergoing catheter ablation for atrial fibrillation.
MedLine Citation:
PMID:  21057900     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Periprocedural thromboembolic and hemorrhagic events are complications of percutaneous radiofrequency catheter ablation (RFA) of atrial fibrillation (AF). The management of anticoagulation before and after RFA could play an important role in the prevention of these complications. The incidence of thromboembolic events varies from 1% to 5%, depending on the ablation and the anticoagulation strategy used in the periprocedural period. The scientific evidence behind the management of anticoagulation in patients with AF undergoing RFA is scarce and is mostly based on small studies and experts' consensus. It remains unclear whether catheter ablation for AF reduces the risk of stroke and obviates the need for anticoagulation after the procedure. Limited data are available regarding the risk of thromboembolism with and without warfarin after AF ablation. In this review we will review the most current evidence supporting the different strategies to reduce thromboembolic risk before, during, and after catheter ablation for AF.
Authors:
Juan F Viles-Gonzalez; Davendra Mehta
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current cardiology reports     Volume:  13     ISSN:  1534-3170     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-06     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  38-42     Citation Subset:  IM    
Affiliation:
Cardiovascular Institute, Mount Sinai Hospital, Mount Sinai School of Medicine, New York, NY 10029, USA. juan.viles-gonzalez@mssm.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  How to optimize current (available) diagnostic tests.
Next Document:  Common factors in empirically supported treatments of borderline personality disorder.